XML 18 R6.htm IDEA: XBRL DOCUMENT v3.19.1
Unaudited Condensed Consolidated Statements of Shareholders' Equity - USD ($)
$ in Thousands
Additional Paid-in Capital [Member]
Accumulated Other Comprehensive Income (Loss) [Member]
Retained Earnings [Member]
Total
Class A [Member]
Common Stock [Member]
Class A [Member]
Class B [Member]
Common Stock [Member]
Class B [Member]
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Cumulative effect of adoption, net of tax | ASU 2016-01 [Member] $ 0 $ (46,157) $ 46,157 $ 0 $ 0   $ 0  
Cumulative effect of adoption, net of tax | ASU 2018-02 [Member] 0 117 (117) 0 0   0  
Beginning balance at Dec. 31, 2017 55,078 46,391 316,700 418,811 $ 112   $ 530  
Beginning balance (in shares) at Dec. 31, 2017         2,623,000   12,424,000  
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Net income 0 0 330 330 $ 0   $ 0  
Foreign currency translation adjustment, net of tax 0 (223) 0 (223) 0   0  
Change in unrealized gain (loss) on investments, net of tax 0 (3,121) 0 (3,121) 0   0  
Common stock dividends 0 0 (4,229) (4,229) 0   0  
Repurchase of common stock (45) 0 (190) (235) 0   $ 0  
Repurchase of common stock (in shares)             (11,000)  
Restricted stock grants 478 0 0 478 $ 0   $ 0  
Restricted stock grants (in shares)         0   5,000  
Ending balance at Mar. 31, 2018 55,511 (2,993) 358,651 411,811 $ 112   $ 530  
Ending balance (in shares) at Mar. 31, 2018         2,623,000   12,418,000  
Beginning balance at Dec. 31, 2018 54,720 (7,347) 308,075 356,082 $ 112   $ 522  
Beginning balance (in shares) at Dec. 31, 2018         2,615,000   12,254,000  
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Net income 0 0 2,748 2,748 $ 0   $ 0  
Foreign currency translation adjustment, net of tax 0 307 0 307 0   0  
Change in unrealized gain (loss) on investments, net of tax 0 8,456 0 8,456 0   0  
Common stock dividends 0 0 (1,493) (1,493) 0   0  
Repurchase of common stock (108) 0 (359) (468) $ 0   $ (1)  
Repurchase of common stock (in shares)         0 (100) (25,000) (24,858)
Restricted stock grants 437 0 0 438 $ 0   $ 1  
Restricted stock grants (in shares)         0   20,000  
Ending balance at Mar. 31, 2019 $ 55,049 $ 1,416 $ 308,971 $ 366,070 $ 112   $ 522  
Ending balance (in shares) at Mar. 31, 2019         2,615,000   12,249,000